Bivalent inhibitors of the tyrosine kinases ABL and SRC: Determinants of potency and selectivity

Ítems similars

• Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src
  per: Hari, Sanjay B., et al.
  Publicat: (2013)
• Targeting Diverse Signaling Interaction Sites Allows the Rapid Generation of Bivalent Kinase Inhibitors
  per: Hill, Zachary B., et al.
  Publicat: (2011)
• Bivalent inhibitors of c-Src tyrosine kinase that bind a regulatory domain
  per: Johnson, Taylor K., et al.
  Publicat: (2016)
• Bivalent Inhibitors of Protein Kinases
  per: Gower, Carrie M., et al.
  Publicat: (2014)
• Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
  per: Bieerkehazhi, Shayahati, et al.
  Publicat: (2016)